SHARE

inHEART secures $11M to optimise cardiac care

20th May 2024

EIT Health-supported start-up, inHEART, has recently raised $11M funding to drive commercial growth of its AI driven software solution for cardiac ablation procedures and develop more advanced 3D cardiac models that can predict heart failure, sudden cardiac death, and cardio-embolic stroke caused by cardiac issues.

Todor Jeliaskov, Chairman and CEO of inHEART, said: “This new funding allows us to go further in addressing the needs of cardiac patients from early screening and disease detection through to advanced therapeutic support.”

About inHEART

Founded in 2017, inHEART is a deep tech, healthcare start-up based in Pessac, France (HQ) with a US subsidiary in Boston, who have developed the world’s first AI-driven, digital twin of the heart to advance the care of patients living with cardiac disease.

Addressing the challenges of conventional cardiac ablations, inHEART’s current solution creates highly detailed, interactive 3D heart models with proprietary AI-driven cardiac CT or MR image segmentation. These 3D models of the heart allow physicians to optimise treatment strategies based on each patient’s unique cardiac anatomy and to support pre-procedural planning for faster ablation procedures and improved clinical outcomes.

How EIT Health has supported inHEART

inHEART has participated in several EIT Health programmes and events: EIT Health Catapult and Summit in 2019, the Bridgehead programme and AI Health event in 2020, and Fast Track EIC in 2021 along with the 2021 Amplifier programme.

inHEART is the project leader in EIT Health’s start-up project inEurHeart which is an innovation project in “Artificial Intelligence, Digital Twin & Clinical Trial for a Disruption in Catheter Ablation for Ventricular Tachycardia” and aims to optimise resource efficiency. Due to conclude in 2024, it is one of our largest clinical studies with 14 study sites in France, Germany, Austria, and Switzerland.

Marc Julien, Managing Director, France & Senior Director Accelerator said “EIT Health France has been delighted to support the inHEART team along their journey so far. Our EIT Health Accelerator and Venture Centre of Excellence (VCoE) colleagues have supported the company with access to finance support and expertise and have facilitated connections to our comprehensive network of pan-European partners. AI in health is a key priority today in Europe and beyond and inHEART plays a key role here as they develop AI tools to improve planning, accuracy and efficiency in surgery.”

Todor Jeliaskov, Chairman and CEO of inHEART said At inHEART, we are committed to addressing the needs of cardiac patients through early screening, disease detection, and advanced therapeutic support. We are proud to collaborate with EIT Health, which helps us improve our AI capabilities and gather additional clinical evidence. It’s exciting for EIT Health and inHEART to be at the forefront of transforming the healthcare industry with the power of AI technology by improving the efficiency of care, quality of decision-making, and effectiveness and safety of medical interventions.” 

Is your start-up looking for support to grow? Discover EIT Health’s portfolio of programmes.

Perspectives on the HealthTech ecosystem

Perspectives on the HealthTech ecosystem

Key takeaways from the health.tech conference 2024

Find out more

Europe’s next generation of elite health innovation start-ups recognised

Europe’s next generation of elite health innovation start-ups recognised

Catapult winners announced

Find out more

SkillSync named as finalist in European Digital Skills Awards 2024

SkillSync named as finalist in European Digital Skills Awards 2024

Learn more.

Find out more